Nevertheless, GLI antagonists GANT-61 and -58 and Arsenic Trioxide (As2O3) have been developed but, to our knowledge, have not been tested in gliomas yet [31,32,33]. The gene discussed is GLI1; the disease is central nervous system cancer.